fbpx

11:00 – 11:45 EET

OPENING – GREETINGS

Korina Pateli- Bell, President of FairLife Lung Cancer Care
Epiphanius, Bishop of Talantia, Representative of the Archdiocese of Athens
Michalis Chryssochoidis, Minister of Health
Marios Themistocleous, Deputy Minister of Health
Sotiris Tsiodras, Professor of Medicine and Infectious Diseases, National and Kapodistrian University of Athens, Director, 4th Dept. of Internal Medicine, «Attikon» Hospital, President, Infectious Diseases Society, President, National Public Health Committee
Karen Kelly (MD), CEO IASLC, Professor Emeritus University of California, Davis
Dimitris Kontopidis, President European Lung Foundation
Ewelina Szmytke, Vice President Lung Cancer Care (LUCE)

11:45 – 12:00 EET

INTRODUCTION

THE LUNG CANCER LANDSCAPE IN GREECE

Mina Gaga, Pulmonologist, former Deputy Minister of Health, Member of the Standing Committee of the World Health Organization (WHO) Regional Committee for Europe

12:00 – 12:50 EET

PREVENTION & EARLY DIAGNOSIS

LATEST DEVELOPMENTS & CHALLENGES

12.05 – 12.15
Latest developments and challenges to lung cancer screening
Georgia Hardavella, MD, MSc, PhD, Consultant, Chest Physician, “Sotiria” Athens Chest Diseases Hospital. Chair, Lung Cancer Group (11.01), European Respiratory Society(ERS). Chair, Lung Cancer Group, Hellenic Thoracic Society. Fellowships and Awards Working Group Member, European Respiratory Society(ERS). Secretary, European Board of Accreditation in Pulmonology(EBAP).
Eleftherios Zervas, Pulmonologist, Head of the 7th Respiratory Dept. Athens Chest Hospital “Sotiria”, Secretary General of the Hellenic Thoracic Society(HTS).


12.15 – 12.50
Discussion: Next steps & recommendations
Stelios Loukidis, MD, PhD, FCCP, FERS, Pulmonologist Professor, University of Athens, Medical School ERS Educational Council President of the Hellenic Thoracic Society (HTS)
Helena Linardou, MD, PhD, Medical Oncologist Director of the 4th Oncology Clinic – Metropolitan Hospital, President of the Scientific Committee of HeCOG (Hellenic Cooperative Oncology Group), Board Member of FairLife L.C.C.
Evi Hatziandreou (MD, DrPH), Dr. of Public Health, University of Harvard, Vice President of FairLife L.C.C
Jesme Fox, Medical Director, Roy Castle Lung Cancer Foundation, UK and Secretary, Global Lung Cancer Coalition
Fofi Kalyva, Secretary General of Public Health

12:50 – 13:00 EET

Break

13:00 – 14:00 EET

SECTION A

LUNG CANCER DIAGNOSIS

Defining the lung cancer diagnosis

13.00 – 13.30
What occurs and what should occur around a lung cancer diagnosis? What is the role of the multidisciplinary team?
Nikolaos Tsoukalas, MD, MSc, PhD, Medical Oncologist, MSc in Bioinformatics, Director, Oncology Dpt. 401 General Military Hospital, Consultant, Henry Dunant Hospital Center
Grigoris Stratakos MD, PhD, FCCP, Professor of Respiratory Medicine and Interventional Pulmonology, 1st Respiratory Medicine Dpt., N.K. University of Athens, “Sotiria” Hospital
Ioannis Vamvakaris MD, MSc, PhD, Pathologist, Head of Pathology Department, “Sotiria” Athens Hospital


13.30 – 14.00
Discussion: Next steps & recommendations 
Zenia Saridaki, MD, PhD,Oncologist, President of the BoD of the Hellenic Society of Medical Oncology (HeSMO), Director,1st Oncology Dept., Metropolitan Hospital, Athens, Scientific Director of Oncology Dept. “Asklepios DIAGNOSIS”, Heraklion Crete
Sandy Tavernaraki, MD, MSc, PhD, Radiologist, Consultant A’, Department of Imaging and Interventional Radiology, “Sotiria ” Hospital, Athens, Greece, Secretary General of Hellenic Radiological Society
Epameinondas Kosmas MD, PhD, FCCP,Scientific Director, Athens Lung Institute, Director, Dept. of Respiratory Medicine PNOI, Metropolitan Hospital, Assoc. Professor, Medical School, University of Nicosia (UNIC), Cyprus
George Kapetanakis, President, Hellenic Cancer Federation (ELLOK)
Athina Baroufi, Patient – Survivor

14:00 – 14:10 EET

Break

14:10 – 15:00 EET

SECTION B

LUNG CANCER – EARLY STAGE

What are the expectations of early diagnosed patients in Greece today?

14.05 – 14.15
Latest Thoracic Surgical Procedures
Michael Klimatsidas, MSc, PhD, FRCS(Gla), Thoracic Surgeon, Scientific Director, Department of Minimally Invasive Thoracoscopic and Robot- assisted Thoracic Surgery, St. Luke’s Clinic


14.15 – 14.25
Contemporary radiation therapy
George Pissakas MD, PhD,Radiation Oncologist, Radiotherapy Unit, Medical School, National University of Athens, Head of Radiation Oncology Dpt., Alexandra General Hospital, Athens, Ex President of the Hellenic Society of Radiation Oncology


14.25 – 14.35
Systemic therapies for potentially curable lung cancer
Petros Christopoulos (MD, PhD), Medical Oncologist, Hematologist, Professor of Medicine, Heidelberg University


14.35 – 15.00
Discussion: Next steps & recommendations 
Helena Linardou, MD, PhD, Medical Oncologist Director of the 4th Oncology Clinic – Metropolitan Hospital, President of the Scientific Committee of HeCOG (Hellenic Cooperative Oncology Group), Board Member of FairLife L.C.C.
Kosmas Iliadis, MD, PhD, FETCS, Thoracic Surgeon, Head of Thoracic Surgery Dpt. Hygeia Hospital, Athens, President, Hellenic Cardiovascular & Thoracic Society of Surgeons (HCTSS)
Ioannis Georgakopoulos MD, PhD, Assistant Professor, Radiation Oncology, National and Kapodistrian University of Athens
Michalis Nikolaou, MD, MSc, PhD, Medical Oncologist, Senior Consultant, Medical Oncology Clinic, General Anticancer Hospital “Agios Savvas”, Vice President, Hellenic Society of Medical Oncology (HeSMO)

15:00 – 15:30 EET

Lunch Break

15:30 – 16:25 EET

SECTION C

METASTATIC LUNG CANCER

Treating metastatic lung cancer in Greece

15.30 – 15.40
How immunotherapy works to treat lung cancer?
Ilias Athanassiadis, Medical Oncologist, Director of Oncology Clinic “MITERA” Hospital, Ass. Professor of Oncology, NORTHWESTERN UNIVERSITY CHICAGO


15.40 – 15.50
Targeted therapies
Ioannis Mountzios, MD, MSc, PhD, Medical Oncologist, Director, 4th Oncology Department and Clinical Trials Unit, Henry Dunant Hospital, Oncolife Institute Founder


15.50 – 16.00
Latest therapies
Petros Christopoulos (MD, PhD), Medical Oncologist, Hematologist, Professor of Medicine, Heidelberg University


16.00 – 16.25
Discussion: Next steps & recommendations
Evi Orfanou, Vice President C’, Greek Patients’ Association
Athina Christopoulou, MD, PhD
Medical Oncologist, Head of Oncology Unit, St. Andrews General Hospital, Patras

16:25 – 16:30 EET

Break

16:3017:20 EET

SECTION D

LIVING WITH LUNG CANCER

16.30 – 16.40
Side effects & Adjuvant therapies
Ioannis Boukovinas, MD, PhD, PharmaD, Scientific Director, Oncology Unit, Bioclinic Thessaloniki


16.40 – 16.50
Νutrition and treatment of sarcopenia In lung cancer
Stavroula Droufakou, Consultant Medical Oncologist, 5th Dpt. Of Medical Oncology, IASO General Clinic


16.50 – 17.00
Prevention – Vaccination
Vissaria Sakka, MD, PHD, Internal Medicine and Infectious Diseases Specialist, Senior Registrar, 3rd Department of Internal Medicine, Medical School, University of Athens, “Sotiria” Hospital of Athens


17.00 – 17.20
Discussion
Paris Kosmidis, Medical Oncologist, Head of 2nd Medical Oncology Clinic, Hygeia Hospital
Dimitrios Papageorgiou,Assistant Professor, University of Peloponnese, Head Nurse Oncology Unit, Euroclinic Athens, President of Hellenic Oncology Nursing Society
Zoe Grammatoglou,President, Κ.E.F.I. association
Cynthia Mikkelsen, Caregiver – Communication expert
Kiki Tsakaldimi, Ambassador, Board Member of FairLife L.C.C.

17:20 – 17:25 EET

Break

17:25 – 18:10 EET

SECTION E

LUNG CANCER & STIGMA

17.25 – 17.35
FairLife L.C.C.‘s campaign
Aggeliki Souri, Patient Advocate, Board Member of FairLife L.C.C.
Thomais Sarakinioti, Project Manager FairLife L.C.C.


17.35 – 18.10
Medical community discussion
Ioannis Boukovinas, MD, PhD, PharmaD, Scientific Director, Oncology Unit, Bioclinic Thessaloniki
Dimitra Kanaloupitis MD, Medical Oncologist, Director, 4th Oncology Clinic, IASO Hospital
Athanassios Vozikis, Professor, Director of the Laboratory of Health Economics & Management (LabHEM), Economics Dept., University of Piraeus
Paraskevi Katsaounou, Assistant Professor of Respiratory Medicine, National Kapodistrian University of Athens, Respiratory Dept., First ICU Evangelismos Hospital, Athens, Greece
Caius Kim, Global Director, AstraZeneca, Lung Ambition Alliance

18:10 – 18:40 ΕΕΤ

CONFERENCE SPONSORS

Evi Dalakaki, Health Policy Lead, MSD Greece
Thanasis Akalestos
, Head of Medical Scientific Affairs & Healthcare Development, Roche Diagnostics (Hellas)
Aristidis Nikolaou, MD, MSc,Pneumonologist, Medical Manager Oncology Lung, AstraZeneca
George Tsakalakis, Corporate & Government Affairs Lead, BMS Greece
Aimilia Kassotaki, Patient Engagement & Advocacy Specialist, Janssen
Andreas Roussidis, Ph.D, Country Medical Director GSK

18:45 – 19:00 EET

CLOSING – CONCLUSIONS

Presentation – Coordination: Elena Papadimitriou, Journalist

Any information provided on diseases is intended for the purpose of providing general information to the public and under no circumstances can it substitute the advice of a doctor or other competent health professional.